1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6703BF3821C72038D0025854B002AB709
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-thought-leader-management-excellence-services-technology-enablement-assessing-external-stakeholder-engagement-success?opendocument
18
19opendocument
2018.213.192.104
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Thought Leader Services

Thought-leader Management Excellence: Services, Technology Enablement and Assessing External Stakeholder Engagement Success

ID: 5610


Features:

8 Info Graphics

7 Data Graphics

100+ Metrics

2 Narratives


Pages/Slides: 22


Published: 2020


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Thought-leader Management Excellence: Services, Technology Enablement and Assessing External Stakeholder Engagement Success”

STUDY OVERVIEW

Thought-leader engagement and relationships have been and remain a critical component of success in the biopharmaceutical industry – from the early development stage through post market entry.

Companies must have technologically-enabled and data-backed thought-leader management systems to nurture the right relationships with the right thought leaders at the right times.

Best Practices, LLC undertook this benchmarking research to help Medical Affairs leaders develop optimal thought-leader management systems across key program dimensions. This research enables Medical Affairs leaders to improve performance and make better decisions by helping them assess the impact of identification, engagement, technology enablement and performance measurement of their thought-leader management systems.

KEY TOPICS
  • Optimal Thought Leader Identification, Engagement, and Services
  • Technology Enablement in Thought Leader Management
  • Measuring Thought Leader Management & Engagement

KEY METRICS
  • What are the top three things thought leaders seem to value most in their relationship with your company – based on feedback you’ve received from them?
  • How important are each of the listed Thought-leader services?
  • Which Thought-leader activities are most valued by your company?
  • How involved are your company’s Medical Science Liaisons (MSLs) in Thought-leader identification?
  • Do you have a tool for a global line of sight on all Thought-leader activities, including contracting?
  • What types of strategic Thought-leader management and engagement activities are supported by the system/tools/software used at your company and how effective are those components?

SAMPLE KEY FINDINGS
  • Technology Enablement: Organizations use 2-3 tools/tech systems on average, finding limited effectiveness across many dimensions.

METHODOLOGY

Best Practices, LLC engaged 35 biopharma leaders at 31 companies through a benchmarking survey instrument, interviews and a roundtable discussion in this research.


Industries Profiled:
Pharmaceutical; Biopharmaceutical; Consulting; Biotech; Medical Device; Manufacturing; Health Care; Clinical Research; Laboratories


Companies Profiled:
Adamas Pharmaceuticals; Alkermes; Alligent Group; Amgen; Antiva Bioscience; Asofarma; Beckman Coulter; Biogen; Boston Scientific; Cipla; Eisai; EMD Serono; Fidia; Fresenius Medical Care; Galderma; IQVIA; LEO Pharma; Melinta Therapeutics; Inc; Merck; Merck Healthcare KGaA; Mylan; Novartis; Nutricia; Pfizer; Rakuten Medical; Sanofi; Santen; Servier; Shire; Takeda Pharmaceuticals; Terumo Corporation; Teva Pharmaceutical Industries Ltd

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.